Determination of Drug Interactions of Certain Nasal Medications With Intranasal Ketamine
Status:
Unknown status
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
This is an open label, single-center study to determine whether certain nasal medication
interact with PMI-150 (intranasal ketamine) 30 mg in healthy adult volunteers and in patients
with allergic rhinitis.